PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic ovary syndrome |
| Symptom | C0242339|dyslipidemia |
| Sentences | 7 |
| PubMedID- 22276997 | Background: there is a high prevalence of diabetes mellitus (dm) and dyslipidemia in women with polycystic ovary syndrome (pcos). |
| PubMedID- 24327994 | dyslipidemia in women with polycystic ovary syndrome. |
| PubMedID- 23528141 | Background: obesity is known to underlie, at least partially, dyslipidemia in polycystic ovary syndrome (pcos), but it is unclear whether pcos status per se increases the risk of alterations of lipoprotein subfractions, which differ in size and atherogenic potential. |
| PubMedID- 22005616 | dyslipidemia is associated with polycystic ovary syndrome (8), the most common endocrine disorder among women of reproductive age and a leading cause of infertility (9). |
| PubMedID- 20807166 | dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. |
| PubMedID- 21059754 | The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. |
| PubMedID- 23276562 | Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome. |
Page: 1